SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
3274<i>What happened in the 1980's and 1990's was that those norms unrscaram(o)uche10/20/2002
3273(cont'd) But then why weren't executives paid lavishly 30 years ago? Agscaram(o)uche10/20/2002
3272Message 18134951 nytimes.com October 20, 2002 For Richer By PAUL KRUGMAN I. Tscaram(o)uche10/20/2002
3271Thanks, Tuck! I'm very close to this one. Hindsight insight. Always correscaram(o)uche10/18/2002
3270EuroVC Gunnar Weikert commenting on business models, mostly wrt genomics companituck10/18/2002
3269IDEC third-quarter profit rises 42 pct Wednesday October 16, 6:12 pm ET By Descaram(o)uche10/16/2002
3268Chiron Announces Financial Results For Third Quarter Expected to Exceed Expectatscaram(o)uche10/14/2002
3267Genentech Reports 23 Percent Increase in Product Sales for Third Quarter 15 Perscaram(o)uche10/9/2002
3266Filer: BVF PARTNERS LP Position: Beneficial Owner (10% or more) Stock Symbol: Adalroi10/9/2002
3265Biotech firms go prospecting for venture capital Despite tight economy, CEsim110/3/2002
3264>> Didn't jump in << Good news! Thanks for letting me know.scaram(o)uche10/2/2002
3263Richard,Thanks anyway.Didn't jump in,Thank God!Will be lurking,Thanks Jerrycavan10/2/2002
3262>> Do you think it is a buy under 2.00? << Sorry, I thought you saiscaram(o)uche10/1/2002
3261for those who don't know about these...... Subject 53345 Subject 53337 Subjscaram(o)uche10/1/2002
3260>> The fall as a result of the disclosure event is BS << Belongs inscaram(o)uche10/1/2002
3259IDEC Pharmaceuticals and Nippon Shinyaku Sign License Agreement to Develop Novelscaram(o)uche9/30/2002
3258I have been thinking about it... Let's even assume the IPO was over-priced.mopgcw9/30/2002
3257BVF bought into INSM prior to the recent results. I wonder if they are still homopgcw9/30/2002
3256Given the performance, it absolutely stuns me that ANYONE is buying DOVP. :-( scaram(o)uche9/30/2002
3255I believe it was somewhere noted that BVF recently bought a bunch of Insmed, whituck9/30/2002
3254Jerry: Traditionally, this thread is not used for stock-specific discussion. Hscaram(o)uche9/30/2002
3253Hi Richard,What is your take on ELN? Do you think it is a buy under 2.00? Thankscavan9/30/2002
3252Triangle: Once-Daily Coviracil Regimen Superior To Zerit Friday September 27, 1scaram(o)uche9/27/2002
3251Phase III, 24-Week Results for the NEAT Trial Comparing GW433908 (908) to Nelfinscaram(o)uche9/27/2002
3250Sign of the times: Decode inks 'landmark alliance' with Merck... and slinigel bates9/27/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News